logo
Plus   Neg
Share
Email

IBM Canada, Celero Sign Outsourcing Deal For Hybrid Cloud, Data Centre Modernization

IBM Canada, affiliated to International Business Machines Corp. (IBM), announced Tuesday that it has signed a 7-year, multi-million dollar strategic outsourcing agreement with Celero, a provider of digital technology and integration solutions for Canadian credit unions.

The deal includes secure cloud services, resiliency testing, threat management, disaster recovery support and process automation.

The agreement is expected to modernize and transform Celero's data centre and data centre network environments, moving their infrastructure services onto a hybrid cloud environment.

Under the deal, Celero expects to significantly advance the digital banking technologies, cloud services, security and payment solutions they provide to more than 110 credit unions and financial institutions across Canada. It will also position their capabilities to support business and economic recovery from the implications of COVID-19.

Tom Papagiannopoulos, senior vice president at Celero, said, "To deliver on our clients' digital ambitions and accelerate their recovery from COVID-19, it's critical for Celero to embark on this innovative path forward with our long-standing collaborator, IBM. The transformational opportunities of moving to a hybrid IBM Cloud platform will result in Celero and our clients becoming more agile, resilient and forward-looking, which will ultimately translate to a superior experience for credit union members."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Despite the coronavirus pandemic, retailers are prepared for an early start to the holiday shopping season by offering discounts earlier so that consumers can buy and receive the gifts they want in time, the National Retail Federation or NRF said. The NRF also said it is launching a nationwide consumer education campaign called "New Holiday Traditions". Facebook (FB) has revealed new messaging features for Instagram, which will make it easier for users to stay in touch with others across Facebook's family of apps. The main change is that people using the Messenger app can now reach Instagram users, and vice versa. The users can control where they receive... Regeneron Pharmaceuticals, Inc. announced positive first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 in COVID-19 patients. REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients. The company said it plans rapidly to discuss results with regulatory authorities.
Follow RTT